Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Antineoplastic Combined Chemotherapy Protocols MeSH Descriptor Data 2026


MeSH Heading
Antineoplastic Combined Chemotherapy Protocols
Tree Number(s)
E02.183.750.500
E02.319.077.500
E02.319.310.037
Unique ID
D000971
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000971
Annotation
coordinate IM with specific antineoplastic agents (IM or NIM)
Scope Note
The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.
Entry Term(s)
Anticancer Drug Combinations
Antineoplastic Agents, Combined
Antineoplastic Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Regimens
Antineoplastic Drug Combinations
Cancer Chemotherapy Protocols
Chemotherapy Protocols, Antineoplastic
Combined Antineoplastic Agents
Drug Combinations, Antineoplastic
NLM Classification #
QZ 267
Previous Indexing
Drug Therapy, Combination (1974-1983)
Public MeSH Note
2002; see ANTINEOPLASTIC AGENTS, COMBINED (1984-2001)
History Note
2002(1984)
Date Introduced
1984/01/01
Last Updated
2015/06/23
Antineoplastic Combined Chemotherapy Protocols Preferred
Antineoplastic Chemotherapy Protocols Broader
page delivered in 0.121s